| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |